Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 38%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is a leader in the medical technology industry, with strong Q2 revenue and a successful product line, including the innovative breast implant product, Motiva. With a growing list of distributors and accounts globally, and an expanding product line, the company is expected to see long-term growth and strong revenue contribution. Combined with a successful cash flow outlook and a low complication rate for their tissue-preserving procedure, Establishment Labs Holdings Inc is a strong buy for investors.

Bears say

Establishment Labs Hldgs is expected to face significant challenges in the near future due to inventory reserves, increased operating expenses, and potential funding needs. While the company has a strong cash balance and plans to reach free cash flow positivity by 2026, the risks of an economic recession, competition, and unsuccessful launch of pipeline products could hinder its progress. However, the company's innovative R&D and attractive gross margin may warrant a higher valuation in the MedTech sector.

ESTA has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 38% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 8 analysts, ESTA has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.